Awards/PROJECT GRANT (B)

$105,895,280

Department of Health and Human Services·National Institutes of Health

to CASE WESTERN RESERVE UNIVERSITY

biotechactive

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_P30CA043703_075

Award description

CASE COMPREHENSIVE CANCER CENTER SUPPORT GRANT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Supports Case Western Reserve University's comprehensive cancer center research, infrastructure, and training programs.

Sub-sectors

nih-research-grantcancer-researchacademic-institution

Why this matters

Major NIH investment in academic cancer research strengthens U.S. oncology innovation and clinical trial capacity.

Supply-chain signal

Drives demand for laboratory equipment, reagents, sequencing technology, and specialized medical devices from biotech suppliers.

U.S.–China competition angle

U.S. cancer research leadership depends on sustained NIH funding to maintain competitive advantage in precision medicine and immunotherapy development.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002122.

Period of performance

Start

1997-08-01

End

2030-03-31

Status

activein 1414 days

Recipient

CASE WESTERN RESERVE UNIVERSITY

UEI HJMKEF7EJW69

View full profile →

Other awards from this recipient

See all →

—CASE AIDS CLINICAL TRIALS UNIT$40.0M

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_P30CA043703_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.